SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Full list of Israeli high-tech funding rounds in 2025

Syremis raises $165 million Series A to take on schizophrenia and other severe mental illnesses

Iron Dome and Iron Beam maker Rafael moves closer to a possible IPO

Weapons as strategy: Israel’s defense industry steps into a larger global role

Buzz

Most popular

Daily

Weekly

1

Huang declares Israel Nvidia’s “second home” with record-breaking campus investment

2

Cyera raises $400 million at $9 billion valuation in Blackstone-led round

3

Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation

4

Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal

5

“The acquisition of Armis marks a clear entry by ServiceNow into cybersecurity”

OrbiMed

4 stories about OrbiMed

בריאות דיגיטלית מדעי החיים רפואה טיפול 1

OrbiMed chooses against raising a third Israeli healthcare-dedicated fund

07.01.21|Meir Orbach

The investment firm raised a $307 million fund in 2016, but will not be founding another in a blow to the local ecosystem

Biological cancer treatment company Novellus raises $57 million

22.09.20|Tzally Greenberg

Novellus develops a drug that delays the development of a BRAF gene mutation created in cases of thyroid cancer and glioma cancer

נאסדק נאסד"ק ניו יורק בורסה בועה

OrbiMed Invests $16 Million in Derma Company Foamix

17.04.18|Lilach Baumer

Foamix is a clinical-stage company developing specialty foam-based treatments for skin conditions such as acne

פיטר ת'יל יזם ו משקיע בתחום ה הייטק

Peter Thiel Invests in Israeli Biopharmaceutical Startup ChemomAb

04.12.17|Meir Orbach

ChemomAb develops an antibody treatment for inflammatory and fibrotic diseases